Immunoepigenetics: the unseen side of cancer immunoediting (Q36666346)

15 August 2017

1 reference

title

Immunoepigenetics: the unseen side of cancer immunoediting (English)

1 reference

15 August 2017

Germenis AE

1

1 reference

PubMed ID

17130900

15 August 2017

Karanikas V

series ordinal

2

1 reference

15 August 2017

28 November 2006

1 reference

Immunology & Cell Biology

15 August 2017

1 reference

15 August 2017

85

1 reference

15 August 2017

1

1 reference

15 August 2017

55-59

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.icb.7100006

15 August 2017

0 references

cites work

Rational approaches to human cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Cancer immunotherapy: breaking the barriers to harvest the crop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

The critical role of type-1 innate and acquired immunity in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Immunotherapy via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Is cancer dangerous to the immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

CD4+ Tregs and immune control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Heterogeneity of CD4(+) and CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Understanding the generation and function of memory T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Human tumor-specific T lymphocytes: does function matter more than number?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Principles of tumor immunosurveillance and implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Tumour escape: antitumour effectors too much of a good thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Selective MHC expression in tumours modulates adaptive and innate antitumour responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

A critical function for type I interferons in cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Polymorphism in clinical immunology - From HLA typing to immunogenetic profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Evidence for immune defects in breast and lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Mutations and regulatory anomalies effecting tumor cell immune functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Dna methylation in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Methylation and demethylation in the regulation of genes, cells, and responses in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Epigenetic control in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

The history of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Overview of cancer epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Chromatin structure and gene regulation in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smoke-induced neoplastic progression of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Loss of Fas (CD95/APO-1) expression by antigen-specific cytotoxic T cells is reversed by inhibiting DNA methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Relative paradigms between autoantibodies in lupus and autoantibodies in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Systemic autoimmune diseases in elderly patients: atypical presentation and association with neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

DNA methylation and autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Epigenetics and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

The potential contributions of chronic inflammation to lung carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Review article: helicobacter pylori and molecular events in precancerous gastric lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Molecular pathways to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Aberrant methylations in cancer cells: where do they come from?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Oxidative Stress and Gene Transcription in Asthma and Chronic Obstructive Pulmonary Disease: Antioxidant Therapeutic Targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Transcriptional regulation of 15-lipoxygenase expression by promoter methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Gene silencing in mammalian cells and the spread of DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

The role of DNA methylation in mammalian epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Reduced expression and promoter methylation of p16 gene in Epstein-Barr virus-associated gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Identification of aberrantly methylated genes in association with adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Immunosuppressive therapy for patients with refractory anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Persistent remission after immunosuppressive therapy of hairy cell leukemia mimicking aplastic anemia: two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

New agents in acute myeloid leukemia and other myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Relevance of DNA methylation in the management of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Epigenetic silencing of multiple interferon pathway genes after cellular immortalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Modern criteria to establish human cancer etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Alcohol and cancer: genetic and nutritional aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Genetics, epigenetics, and the environment: switching, buffering, releasing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

7 January 2021

MCA Sarcomas Induced in scid Mice are More Immunogenic than MCA Sarcomas Induced in Congenic, Immunocompetent Mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

7 January 2021

Type I interferon and cancer immunoediting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

1 reference

7 January 2021

Rheumatic diseases and malignancy--is there an association?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

7 January 2021

Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

7 January 2021

Uptake of foreign DNA by mammalian cells via the gastrointestinal tract in mice: methylation of foreign DNA--a cellular defense mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

7 January 2021

Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

7 January 2021

Increased expression of hepatic DNA methyltransferase in smokers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100006

7 January 2021

Identifiers

DOI

10.1038/SJ.ICB.7100006

1 reference

PubMed ID

17130900

Dimensions Publication ID

15 August 2017

0 references

1 reference

PubMed ID

17130900